Casdin Capital as of March 31, 2018
Portfolio Holdings for Casdin Capital
Casdin Capital holds 31 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Loxo Oncology | 7.3 | $42M | 360k | 115.37 | |
| Foundation Medicine | 7.2 | $41M | 520k | 78.75 | |
| Sage Therapeutics (SAGE) | 7.1 | $40M | 250k | 161.07 | |
| Blueprint Medicines (BPMC) | 5.6 | $32M | 348k | 91.70 | |
| Spark Therapeutics | 5.4 | $31M | 463k | 66.59 | |
| Agios Pharmaceuticals (AGIO) | 5.2 | $30M | 365k | 81.78 | |
| Alnylam Pharmaceuticals (ALNY) | 5.2 | $30M | 250k | 119.10 | |
| Global Blood Therapeutics In | 5.1 | $29M | 600k | 48.30 | |
| Myokardia | 4.8 | $27M | 560k | 48.80 | |
| Sangamo Biosciences (SGMO) | 4.7 | $27M | 1.4M | 19.00 | |
| Fate Therapeutics (FATE) | 4.5 | $25M | 2.6M | 9.76 | |
| Bluebird Bio | 4.3 | $25M | 145k | 170.75 | |
| Codexis (CDXS) | 3.9 | $22M | 2.0M | 11.00 | |
| Voyager Therapeutics (VYGR) | 3.8 | $21M | 1.1M | 18.79 | |
| GenMark Diagnostics | 3.7 | $21M | 3.9M | 5.44 | |
| Illumina (ILMN) | 3.0 | $17M | 72k | 236.42 | |
| Evolent Health (EVH) | 2.8 | $16M | 1.1M | 14.25 | |
| Jounce Therapeutics | 2.5 | $14M | 635k | 22.35 | |
| Audentes Therapeutics | 2.4 | $14M | 450k | 30.05 | |
| Beigene (ONC) | 2.1 | $12M | 70k | 168.00 | |
| iShares NASDAQ Biotechnology Index (IBB) | 1.8 | $10M | 95k | 106.74 | |
| Clovis Oncology | 1.6 | $9.4M | 178k | 52.80 | |
| Crispr Therapeutics (CRSP) | 1.1 | $6.2M | 135k | 45.71 | |
| Cytomx Therapeutics (CTMX) | 1.0 | $5.9M | 208k | 28.45 | |
| Editas Medicine (EDIT) | 0.8 | $4.4M | 133k | 33.15 | |
| Neogen Corporation (NEOG) | 0.8 | $4.4M | 65k | 66.98 | |
| OraSure Technologies (OSUR) | 0.7 | $4.1M | 240k | 16.89 | |
| Celgene Corporation | 0.6 | $3.6M | 40k | 89.20 | |
| Zai Lab (ZLAB) | 0.5 | $2.9M | 135k | 21.35 | |
| Adverum Biotechnologies | 0.3 | $1.7M | 300k | 5.80 | |
| Homology Medicines | 0.2 | $1.1M | 60k | 18.70 |
